SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001279569-19-001264
Filing Date
2019-05-28
Accepted
2019-05-24 20:42:53
Documents
4
Period of Report
2019-05-24

Document Format Files

Seq Description Document Type Size
1 FORM 6-K essa6k.htm 6-K 10228
2 MATERIAL CHANGE REPORT DATED MAY 24, 2019 ex991.htm EX-99.1 22671
3 IMPLEMENTATION AGREEMENT ex992.htm EX-99.2 575362
4 GRAPHIC cooley.jpg GRAPHIC 6898
  Complete submission text file 0001279569-19-001264.txt   618911
Mailing Address SUITE 720 999 WEST BROADWAY VANCOUVER A1 V5Z 1K5
Business Address SUITE 720 999 WEST BROADWAY VANCOUVER A1 V5Z 1K5 (778) 331-0962
ESSA Pharma Inc. (Filer) CIK: 0001633932 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0930
Type: 6-K | Act: 34 | File No.: 001-37410 | Film No.: 19855794
SIC: 2834 Pharmaceutical Preparations